ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Curbstone who wrote (288)	12/11/1998 2:03:00 PM
From: John Miz	Read Replies (1) of 1084

Back when Cowen initiated coverage of this stock, (in March of 1997) their initial price target was 15 dollars per share. In his report, the analyst called for an EPS breakout to $1.00 F2000, and $2.85 in F2001. The Aastrom system was described as being "a razor and blade" business model with compelling revenue and EPS potential. They called the technology commercially practical and easy to use. I think the European launch of this product, coming shortly, should help out the price of ASTM. (500MM+ market) Don't know if Cowen is currently following ASTM. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next